Cannabis improves kidney function

Kidney's & Cannabis studies completed

Overview

Cannabis "marijuana" has not been shown to cause changes or damage to the kidneys. In fact, it has never been shown to cause any kind of permanent damage to the lungs, heart, liver, kidneys, brain or any of the other areas of the body it is said to affect.

As a matter of fact, some studies have actually shown it to help decrease the spread of lung and glioma (brain cancer), and it has been shown to increase sperm production and fertility.

Science and Research

2013 - Report ~ Acute Kidney Injury Associated with Synthetic Cannabinoid Use — Multiple States,

2013 - Study ~ Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis.

2013 - Study ~ β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2
receptor-dependent manner

2013 - Study ~ Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells is Regulated by Albumin Independent of ERK1/2 Signaling.

2013 - Study ~ First Metabolic Profile of XLR-11, a Novel Synthetic Cannabinoid, Obtained by Using Human Hepatocytes and High-Resolution Mass Spectrometry.

2013 - News ~ Synthetic Marijuana Dangerous for Kidneys

2013 - News ~ Synthetic Marijuana Harms Kidneys of 16 Users, CDC Reports

2013 - News ~ Synthetic drugs carry risk of kidney damage

2012 - Study ~ β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.

2012 - Study ~ Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats.

2012 - Study ~ AKI Associated with Synthetic Cannabinoids: A Case Series.

2012 - News ~ Outbreak of kidney failure in Wyoming linked to "Spice"

2012 - News ~ Wyoming kidney failure outbreak linked to designer 'blueberry spice' drug, aka 'legal marijuana'

2012 - News ~ Blueberry “spice” in Wyoming linked to cases of renal failure

2012 - News ~ New health concerns about 'fake pot' in US

2011 - Study ~ Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death.

2011 - Study ~ Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.

2011 - Study ~ Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy.

2011 - Study ~ Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease.

2011 - Study ~ Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease?

2011 - Study ~ Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance.

2010 - Study ~ Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy

2010 - Study ~ Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.

2010 - Study ~ Expression of cannabinoid receptors in human kidney.

2009 - Study - Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4.

2009 - Study ~ The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

2008 - Study - Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor.

2008 - Study - The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney.

2006 - Study - Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells.

2005 - News - Cream with endocannabinoids effective in the treatment of pruritus due to kidney disease.